Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2017 call → NOWe need to determine if management's forward account is largely about counterparties' own scaling. The question asks: does management explain where the company's business is going by narrating what its counterparties are themselves doing and scaling? That is, does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. Management discusses various things: net inflows, product launches, distribution, etc. But specifically, they talk about Japan sub-advisory flows, a distribution partner cutting distribution rate, and they discuss that they have a plan with that partner to have seminars. They also discuss institutional demand for preferreds, and they mention that they have a pipeline. They also discuss DCIO and Europe investments. They talk about their own initiatives. The key is: does management describe counterparties' own scaling? For example, they mention that their largest Japanese distribution partner reduced distribution rate on one fund. That is a reduction, not scaling. They also mention that they have a plan with that partner to have seminars. That is more about their own efforts. They also mention that they are seeing demand from institutions for preferreds, but that is general demand, not specific counterparties' build-out. They also mention that they have a pipeline of mandates, but that is about prospects, not current customers scaling. They mention that they are investing in infrastructure capabilities, but that is their own. They mention that they have a SICAV that received funding from a Japanese institutional investor, but that is a one-time event. They also mention that they have AUA from Taiwanese and Korean funds, but those are new mandates, not scaling of existing counterparties. The question specifically asks: does management explain its outlook by narrating what its counterparties are themselves doing and scaling? The counterparties would be like distributors, partners, etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.